American Vanguard Corporation (AVD)
NYSE: AVD · Real-Time Price · USD
2.850
-0.110 (-3.72%)
At close: Apr 28, 2026, 4:00 PM EDT
2.850
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:10 PM EDT

Company Description

American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets synthetic, biological, and biorational products for agricultural, commercial, and consumer uses in the United States and internationally.

The company synthesizes and formulates chemicals and ferments and extracts microbial products for crops, turf, ornamental plants, and human and animal health protection, such as insecticides, fungicides, herbicides, soil health, plant nutrition, molluscicides, growth regulators, soil fumigants, and biorationals in liquid, powder, and granular forms.

It distributes its products through national distribution companies, buying groups, or co-operatives, as well as through sales offices, wholly owned distributors, sales force executives, and sales agents.

American Vanguard Corporation was incorporated in 1969 and is headquartered in Newport Beach, California.

American Vanguard Corporation
American Vanguard logo
Country United States
Founded 1969
Industry Agricultural Inputs
Sector Materials
Employees 739
CEO Douglas Kaye

Contact Details

Address:
4695 MacArthur Court
Newport Beach, California 92660
United States
Phone 949 260 1200
Website american-vanguard.com

Stock Details

Ticker Symbol AVD
Exchange NYSE
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000005981
CUSIP Number 030371108
ISIN Number US0303711081
Employer ID 95-2588080
SIC Code 2870

Key Executives

Name Position
Douglas A. Kaye III Chairman and Chief Executive Officer
David T. Johnson C.F.A. Chief Financial Officer
Timothy J. Donnelly Esq. Chief Information Officer, General Counsel and Secretary
Shirin Khosravi Chief Human Resource Officer
Jared Stanley Senior Vice President of Supply Chain and Operations
Anthony Young Director of Investor Relations
William A. Kuser Director of Corporate Communications
Michael J. DiPaola Senior Vice President of Strategy, Marketing and Research & Development
Nolteanous Gilliam Senior Vice President of Manufacturing
Robert F. Gilbane President of Gemchem Inc

Latest SEC Filings

Date Type Title
Apr 23, 2026 DEF 14A Other definitive proxy statements
Apr 15, 2026 8-K Current Report
Mar 26, 2026 SCHEDULE 13G/A Filing
Mar 19, 2026 8-K Current Report
Mar 18, 2026 8-K Current Report
Mar 16, 2026 10-K Annual Report
Feb 13, 2026 SCHEDULE 13G/A Filing
Nov 18, 2025 UPLOAD Filing
Nov 12, 2025 SCHEDULE 13G Filing
Nov 12, 2025 8-K Current Report